Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers

Bibliographic Details
Main Authors:	Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2023-01-01
Series:	Clinical and Molecular Hepatology
Subjects:	hepatitis b virus hepatitis b antiviral agents
Online Access:	http://e-cmh.org/upload/pdf/cmh-2022-0333.pdf

Similar Items

Chronic Hepatitis B Infection: New Approaches towards Cure
by: Mojisola Ogunnaike, et al.
Published: (2023-08-01)

ELIMINATING VIRAL HEPATITIS : THE INVESTMENT CASE : Report of the WISH Viral Hepatitis Forum 2018 /
by: Pedrana, Alisa, author, et al.
Published: (2018)

The role of different viral biomarkers on the management of chronic hepatitis B
by: Lung-Yi Mak, et al.
Published: (2023-04-01)

Linvencovir: Paving the way for functional cure in hepatitis B
by: Jiwon Yang, et al.
Published: (2024-04-01)

Randomised controlled trial: effect of metformin add-on therapy on functional cure in entecavir-treated patients with chronic hepatitis B
by: Wei Zhang, et al.
Published: (2022-11-01)

Viral hepatitis B and C. Cure or treatment?
by: Dimitrios A. Kountouras
Published: (2014-12-01)

A study on outcome of hepatic fibrosis in chronic hepatitis B patients on anti-viral therapy
by: Avick Nag, et al.
Published: (2024-02-01)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
by: Maryam Moini, et al.
Published: (2022-03-01)

Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
by: Lung-Yi Mak, et al.
Published: (2023-01-01)

Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy
by: Meng-Ju Lin, et al.
Published: (2023-07-01)

Chronicles of HBV and the Road to HBV Cure
by: Rukaiya Bashir Hamidu, et al.
Published: (2023-04-01)

The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis
by: Danqing Hu, et al.
Published: (2024-04-01)

Current Therapy of Chronic Viral Hepatitis B, C and D
by: Jörg F. Schlaak
Published: (2023-06-01)

Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal study
by: Karin Kan, et al.
Published: (2023-10-01)

Epidemiology and Risk Factors for Acute Viral Hepatitis in Bangladesh: An Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2022-11-01)

Hepatitis B functional cure and immune response
by: Jia-Rui Zheng, et al.
Published: (2022-11-01)

A recurrence of Guillain-Barr and eacute; syndrome or a case of acute-onset chronic inflammatory demyelinating polyneuropathy in the course of chronic hepatitis B?
by: Guner Celik Koyuncu, et al.
Published: (2016-12-01)

Staging Fibrosis in Chronic Viral Hepatitis
by: Ana Carolina Cardoso, et al.
Published: (2022-03-01)

Recent Advances in Hepatitis B Treatment
by: Georgia-Myrto Prifti, et al.
Published: (2021-05-01)

Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01)

Viral Hepatitis in Patients with Inflammatory Bowel Disease
by: Seung Hwan Shin, et al.
Published: (2022-08-01)

Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future
by: Mariana Daniela Ignat, et al.
Published: (2024-04-01)

The new EASL guidelines for the management of chronic hepatitis B infection adapted for Swiss physicians
by: M Alaei
Published: (2010-03-01)

Characteristics of Hepatitis B Co-infection and Disease Evolution in HIV-Positive Paediatric Patients in Romania
by: Manuela Arbune, et al.
Published: (2013-09-01)

The Study of Clinical and Biochemical Parameters in Assessing the Response to the Antiviral Therapy in the Chronic Viral Hepatitis B
by: Alice Elena Ghenea, et al.
Published: (2021-07-01)

Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation
by: Chia-Yeh Lai, et al.
Published: (2021-10-01)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Giacomo Emanuele Maria Rizzo, et al.
Published: (2022-05-01)

Aspartate Aminotransferase to Platelet Ratio Index for the Evaluation of Fibrosis in Chronic Viral Hepatitis
by: M. Arzu YETKİN, et al.
Published: (2006-12-01)

The Changing Epidemiology of Viral Hepatitis in a Post-Soviet Country—The Case of Kyrgyzstan
by: Manas K. Akmatov, et al.
Published: (2023-07-01)

Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
by: Yao-Chun Hsu, et al.
Published: (2023-10-01)

Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis
by: Joo Hyun Oh, et al.
Published: (2022-11-01)

Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B
by: Manasa Suresh, et al.
Published: (2022-08-01)

Correlation between hepatitis B viral load and hepatitis B surface antigen levels in asymptomatic seropositive blood donors
by: Prashant Pandey, et al.
Published: (2023-01-01)

Hepatitis B Virus Cure: Targets and Future Therapies
by: Hye Won Lee, et al.
Published: (2020-12-01)

Seroprevalence of viral hepatitis in riverine communities from the Western Region of the Brazilian Amazon Basin
by: VS de Paula, et al.
Published: (2001-11-01)

Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients
by: Han Ah Lee, et al.
Published: (2022-03-01)

Prevalence of antibodies to hepatitis B core antigen in blood donors in the middle west region of Brazil
by: José Ivan Aguiar, et al.
Published: (2001-02-01)

The Effect of Tenofovir Treatment on Renal Function in Chronic Hepatitis B Patients
by: Yusuf Kayar, et al.
Published: (2019-10-01)

The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysis
by: Georgia Zeng, et al.
Published: (2024-01-01)

Hemophilia Patients’ Level of Knowledge of About Viral Hepatitis
by: Hüsnü PULLUKÇU, et al.
Published: (2016-12-01)